BEVERLY HILLS, Calif., Aug. 01, 2025 (GLOBE NEWSWIRE) — The Arman Gabaee Real Estate Scholarship is now officially open for applications, offering a prestigious opportunity for undergraduate students across the United States to advance their education and career aspirations in real estate. Founded by renowned developer and philanthropist Arman Gabay, this scholarship is designed to […]
NEW YORK, NY / ACCESS Newswire / August 1, 2025 / If you suffered a loss on your Centene Corporation (NYSE:CNC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/centene-corporation-lawsuit-submission-form?prid=159322&wire=1&utm_campaign=15 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
Zions Bancorporation, N.A. (NASDAQ: ZION) announced today that its board of directors (“board”) declared a regular quarterly dividend of $0.45 per common share, an increase of $0.02 per share, or approximately 5%, from the prior quarter. The dividend will be payable August 21, 2025, to shareholders of record at the close of business on August
Arman Gabay Launches Nationwide Real Estate Scholarship to Support the Next Generation of Industry Leaders GlobeNewswire August 01, 2025 BEVERLY HILLS, Calif., Aug. 01, 2025 (GLOBE NEWSWIRE) — The Arman Gabaee Real Estate Scholarship is now officially open for applications, offering a prestigious opportunity for undergraduate students across the United States to advance their education
NEW YORK, NY / ACCESS Newswire / August 1, 2025 / If you suffered a loss on your Fiserv, Inc. (NYSE:FI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/fiserv-inc-lawsuit-submission-form?prid=159315&wire=1&utm_campaign=18 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
NEW YORK, NY / ACCESS Newswire / August 1, 2025 / If you suffered a loss on your Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/rocket-pharmaceuticals-inc-lawsuit-submission-form?prid=159316&wire=1&utm_campaign=19 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
(NASDAQ:SRPT), SAN FRANCISCO, Aug. 01, 2025 (GLOBE NEWSWIRE) — On July 16, 2025, Sarepta Therapeutics (NASDAQ: SRPT) announced a major restructuring that involves, in part, a 36% workforce reduction (500 employees) and other steps to annually save about $400 million. The company also agreed with the FDA to include a black box warning of acute
Sarepta Therapeutics (SRPT) Announces Restructuring and ELEVIDYS Black Box Warning, EMA Recommends Refusal of Marketing Authorization, Securities Class Action Pending – Hagens Berman GlobeNewswire August 01, 2025 SAN FRANCISCO, Aug. 01, 2025 (GLOBE NEWSWIRE) — On July 16, 2025, Sarepta Therapeutics (NASDAQ: SRPT) announced a major restructuring that involves, in part, a 36% workforce reduction
NEW YORK, NY / ACCESS Newswire / August 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Exelixis, Inc. ("Exelixis" or "the Company") (NASDAQ:EXEL). Investors who purchased Exelixis securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/EXEL. Investigation Details
NEWBURYPORT, Mass., Aug. 01, 2025 (GLOBE NEWSWIRE) — A powerful new opportunity for undergraduate students pursuing careers in medicine is now live. The Dr. Guy Navarra Scholarship for Future Doctors officially opens its application cycle, offering a $1,000 award to a driven, passionate student who demonstrates both academic excellence and a clear vision for their